Index by author

May 2009; Volume 50,Issue Suppl 1

A

  1. Aboagye, Eric O.

    1. Monitoring Predominantly Cytostatic Treatment Response with 18F-FDG PET
      Kaiyumars B. Contractor and Eric O. Aboagye
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 97S-105S; DOI: https://doi.org/10.2967/jnumed.108.057273

  2. Avril, Norbert

    1. Response to Therapy in Breast Cancer
      Norbert Avril, Stefanie Sassen and Rebecca Roylance
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 55S-63S; DOI: https://doi.org/10.2967/jnumed.108.057240

B

  1. Barrington, Sally F.

    1. PET/CT for Therapy Response Assessment in Lymphoma
      Martin Hutchings and Sally F. Barrington
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 21S-30S; DOI: https://doi.org/10.2967/jnumed.108.057190

  2. Boellaard, Ronald

    1. Standards for PET Image Acquisition and Quantitative Data Analysis
      Ronald Boellaard
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 11S-20S; DOI: https://doi.org/10.2967/jnumed.108.057182

C

  1. Contractor, Kaiyumars B.

    1. Monitoring Predominantly Cytostatic Treatment Response with 18F-FDG PET
      Kaiyumars B. Contractor and Eric O. Aboagye
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 97S-105S; DOI: https://doi.org/10.2967/jnumed.108.057273

D

  1. de Geus-Oei, Lioe-Fee

    1. Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review
      Lioe-Fee de Geus-Oei, Dennis Vriens, Hanneke W.M. van Laarhoven, Winette T.A. van der Graaf and Wim J.G. Oyen
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 43S-54S; DOI: https://doi.org/10.2967/jnumed.108.057224

  2. Dehdashti, Farrokh

    1. The Role of 18F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and Ovaries
      Julie K. Schwarz, Perry W. Grigsby, Farrokh Dehdashti and Dominique Delbeke
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 64S-73S; DOI: https://doi.org/10.2967/jnumed.108.057257

  3. Delbeke, Dominique

    1. The Role of 18F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and Ovaries
      Julie K. Schwarz, Perry W. Grigsby, Farrokh Dehdashti and Dominique Delbeke
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 64S-73S; DOI: https://doi.org/10.2967/jnumed.108.057257

  4. Dunphy, Mark P.S.

    1. Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET
      Mark P.S. Dunphy and Jason S. Lewis
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 106S-121S; DOI: https://doi.org/10.2967/jnumed.108.057281

F

  1. Fury, Matthew

    1. PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
      Heiko Schöder, Matthew Fury, Nancy Lee and Dennis Kraus
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 74S-88S; DOI: https://doi.org/10.2967/jnumed.108.057208

G

  1. Grigsby, Perry W.

    1. The Role of 18F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and Ovaries
      Julie K. Schwarz, Perry W. Grigsby, Farrokh Dehdashti and Dominique Delbeke
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 64S-73S; DOI: https://doi.org/10.2967/jnumed.108.057257

H

  1. Herrmann, Ken

    1. 18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
      Bernd J. Krause, Ken Herrmann, Hinrich Wieder and Christian Meyer zum Büschenfelde
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 89S-96S; DOI: https://doi.org/10.2967/jnumed.108.057232

  2. Hicks, Rodney J.

    1. Role of 18F-FDG PET in Assessment of Response in Non–Small Cell Lung Cancer
      Rodney J. Hicks
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 31S-42S; DOI: https://doi.org/10.2967/jnumed.108.057216

  3. Hutchings, Martin

    1. PET/CT for Therapy Response Assessment in Lymphoma
      Martin Hutchings and Sally F. Barrington
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 21S-30S; DOI: https://doi.org/10.2967/jnumed.108.057190

J

  1. Jacene, Heather

    1. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
      Richard L. Wahl, Heather Jacene, Yvette Kasamon and Martin A. Lodge
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 122S-150S; DOI: https://doi.org/10.2967/jnumed.108.057307

K

  1. Kasamon, Yvette

    1. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
      Richard L. Wahl, Heather Jacene, Yvette Kasamon and Martin A. Lodge
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 122S-150S; DOI: https://doi.org/10.2967/jnumed.108.057307

  2. Kraus, Dennis

    1. PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
      Heiko Schöder, Matthew Fury, Nancy Lee and Dennis Kraus
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 74S-88S; DOI: https://doi.org/10.2967/jnumed.108.057208

  3. Krause, Bernd J.

    1. 18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
      Bernd J. Krause, Ken Herrmann, Hinrich Wieder and Christian Meyer zum Büschenfelde
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 89S-96S; DOI: https://doi.org/10.2967/jnumed.108.057232

L

  1. Lee, Nancy

    1. PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
      Heiko Schöder, Matthew Fury, Nancy Lee and Dennis Kraus
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 74S-88S; DOI: https://doi.org/10.2967/jnumed.108.057208

  2. Lewis, Jason S.

    1. Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET
      Mark P.S. Dunphy and Jason S. Lewis
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 106S-121S; DOI: https://doi.org/10.2967/jnumed.108.057281

  3. Lodge, Martin A.

    1. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
      Richard L. Wahl, Heather Jacene, Yvette Kasamon and Martin A. Lodge
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 122S-150S; DOI: https://doi.org/10.2967/jnumed.108.057307

O

  1. Oyen, Wim J.G.

    1. Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review
      Lioe-Fee de Geus-Oei, Dennis Vriens, Hanneke W.M. van Laarhoven, Winette T.A. van der Graaf and Wim J.G. Oyen
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 43S-54S; DOI: https://doi.org/10.2967/jnumed.108.057224

R

  1. Roylance, Rebecca

    1. Response to Therapy in Breast Cancer
      Norbert Avril, Stefanie Sassen and Rebecca Roylance
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 55S-63S; DOI: https://doi.org/10.2967/jnumed.108.057240

S

  1. Sassen, Stefanie

    1. Response to Therapy in Breast Cancer
      Norbert Avril, Stefanie Sassen and Rebecca Roylance
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 55S-63S; DOI: https://doi.org/10.2967/jnumed.108.057240

  2. Schöder, Heiko

    1. PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
      Heiko Schöder, Matthew Fury, Nancy Lee and Dennis Kraus
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 74S-88S; DOI: https://doi.org/10.2967/jnumed.108.057208

  3. Schwarz, Julie K.

    1. The Role of 18F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and Ovaries
      Julie K. Schwarz, Perry W. Grigsby, Farrokh Dehdashti and Dominique Delbeke
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 64S-73S; DOI: https://doi.org/10.2967/jnumed.108.057257

V

  1. van der Graaf, Winette T.A.

    1. Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review
      Lioe-Fee de Geus-Oei, Dennis Vriens, Hanneke W.M. van Laarhoven, Winette T.A. van der Graaf and Wim J.G. Oyen
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 43S-54S; DOI: https://doi.org/10.2967/jnumed.108.057224

  2. van Laarhoven, Hanneke W.M.

    1. Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review
      Lioe-Fee de Geus-Oei, Dennis Vriens, Hanneke W.M. van Laarhoven, Winette T.A. van der Graaf and Wim J.G. Oyen
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 43S-54S; DOI: https://doi.org/10.2967/jnumed.108.057224

  3. Vriens, Dennis

    1. Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review
      Lioe-Fee de Geus-Oei, Dennis Vriens, Hanneke W.M. van Laarhoven, Winette T.A. van der Graaf and Wim J.G. Oyen
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 43S-54S; DOI: https://doi.org/10.2967/jnumed.108.057224

W

  1. Wahl, Richard L.

    1. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
      Richard L. Wahl, Heather Jacene, Yvette Kasamon and Martin A. Lodge
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 122S-150S; DOI: https://doi.org/10.2967/jnumed.108.057307

  2. Weber, Wolfgang A.

    1. Assessing Tumor Response to Therapy
      Wolfgang A. Weber
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 1S-10S; DOI: https://doi.org/10.2967/jnumed.108.057174

  3. Wieder, Hinrich

    1. 18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
      Bernd J. Krause, Ken Herrmann, Hinrich Wieder and Christian Meyer zum Büschenfelde
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 89S-96S; DOI: https://doi.org/10.2967/jnumed.108.057232

Z

  1. zum Büschenfelde, Christian Meyer

    1. 18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
      Bernd J. Krause, Ken Herrmann, Hinrich Wieder and Christian Meyer zum Büschenfelde
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 89S-96S; DOI: https://doi.org/10.2967/jnumed.108.057232
Back to top

In this issue